Harlan N Bradford

Title: Harlan N Bradford: Innovator in Peptide Analog Research

Introduction

Harlan N Bradford is a notable inventor based in Lindenwold, NJ (US). He has made significant contributions to the field of peptide analogs, particularly in the context of human kininogen. With a total of 2 patents, his work has implications for biological activity and protease inhibition.

Latest Patents

Bradford's latest patents focus on calpain-inhibiting peptide analogs of the kininogen heavy chain. These synthetic peptide analogs are designed to be conformationally restricted through intramolecular bonding. The peptides effectively mimic the biological activity of human kininogen by inhibiting the activity of calpain, a biologically significant protease. The design of these peptides is based on an equilibrium conformational model of the kininogen heavy chain.

Career Highlights

Harlan N Bradford is affiliated with Temple University, where he continues to advance research in peptide analogs. His innovative work has garnered attention in the scientific community, contributing to the understanding of protease inhibition and its biological significance.

Collaborations

Some of his notable coworkers include Robert W Colman and Bradford A Jameson. Their collaborative efforts have further enriched the research landscape in which Bradford operates.

Conclusion

Harlan N Bradford's contributions to peptide analog research highlight his role as an innovator in the field. His patents and ongoing work at Temple University continue to influence the understanding of biological activity and protease inhibition.